NasdaqGM:EOLSPharmaceuticals
Evolus, Inc. (NASDAQ:EOLS) insiders who sold US$2.4m worth of stock earlier this year are probably glad they did so as market cap slides to US$573m
Over the past year, insiders sold US$2.4m worth of Evolus, Inc. ( NASDAQ:EOLS ) stock at an average price of US$10.69...